Publicacións nas que colabora con Pilar Vázquez Rodríguez (4)
2023
-
Renal profile of patients treated with elvitegravir/ cobicistat/emtricitabine/tenofovir alafenamide fumarate and dolutegravir/abacavir/lamivudine: 120-week results from a real-world cohort
European Journal of Hospital Pharmacy, Vol. 30, Núm. 4, pp. 221-226
2022
-
Discontinuation due to neuropsychiatric adverse events with efavirenz-and dolutegravir-based antiretroviral therapy: a comparative real-life study
European Journal of Hospital Pharmacy, Vol. 29, Núm. 4, pp. 207-211
-
Safety and Immunogenicity of SARS-CoV-2 vaccines in people with HIV
AIDS, Vol. 36, Núm. 5, pp. 691-695
2019
-
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine
Basic and Clinical Pharmacology and Toxicology, Vol. 124, Núm. 4, pp. 479-490